Hospital did not ask surgeon to leave after high level of infections
Accreditation Connection, September 8, 2008
Although Douglas Wallace, MD, a cardiac surgeon previously linked to a high level of patient infections at Saint Agnes Medical Center in Fresno, CA, is leaving, the hospital says he was not asked to leave, according the Fresno Bee.
When state and federal investigators looked into the high rate of infections, the majority could be linked with a particular surgeon with 'questionable practices," but they did not name the surgeon. The state had closed the cardiac surgery program for a week due to infections.
Robert Smittcamp, chairman of the Saint Agnes board of trustees, says Wallace's departure had nothing to do with the high level of infections, which spiked after the hospital launched a cardiac surgery team, including Wallace.
Saint Agnes plans to create a new infection control policy, which will include more tracking of patients after discharge, according to the Fresno Bee.
To read more, click here.
Comments
0 comments on “Hospital did not ask surgeon to leave after high level of infections ”
Related Products
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: TPO disclosures to a business associate
- Q/A: Coding infusions to correct low potassium levels
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- The debate continues: Nurses who reported physician to the Texas Medical Board file federal appeal
- State medical board will hear unprofessional charges against OB-GYN
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- Major mobile operators to support free text alerts
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding infusions to correct low potassium levels
- Know criteria for coverage when podiatrists use Dermagraft® tissue substitute
- Note: Clarification of reference (non-patient) laboratory testing
- HIPAA Q&A: TPO disclosures to a business associate
- Get the facts on coding for non-biodegradeable drug delivery implants
- Facility E/M Levels, 2009 OPPS
- Do not separately report defibrillation
- Defining 'integral' for self-administered drugs is challenging
- Consider the big picture before querying physicians
- Searched
